303 participants
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-24
- Start Date:
- 2025-05-01
- Completion:
- 2027-05-31
Conditions
- Solid Tumor
- Advanced Solid Tumor
- Metastatic Solid Tumor
- Immune Sensitive Tumor
Interventions
- BIOLOGICAL
- DRUG
No Results Yet